Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials

Alzheimer's and Dementia

Volumn 4, Issue 6, 2008, Pages 390-394

  Connor, Donald J ^a   Sabbagh, Marwan N ^a   Cummings, Jeffery L ^b  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Administration; Alzheimer's; Clinical trial; Dementia; Neuropsychiatric Inventory; NPI; Procedure

Indexed keywords

ALZHEIMER DISEASE; BEHAVIOR DISORDER; CAREGIVER BURDEN; CLINICAL PROTOCOL; DISEASE SEVERITY; DISTRESS SYNDROME; EDITORIAL; FREQUENCY ANALYSIS; HUMAN; MEDICAL RESEARCH; MORBIDITY; NEUROPSYCHIATRIC INVENTORY; PRIORITY JOURNAL; QUESTIONNAIRE; SAMPLING; SCORING SYSTEM;

ALZHEIMER DISEASE; CAREGIVERS; CLINICAL TRIALS AS TOPIC; DEMENTIA; HUMANS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 55549104400     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2008.09.002     Document Type: Editorial

References (7)

1. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., and Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (1994) 2308-2314
2. Barcia D., Giles E., Herraiz M., Morinigo A., Roca M., and Rodriguez A. Risperidone in the treatment of psychotic, affective, and behavioral symptoms associated to Alzheimer's disease. Actas Esp Psiquiatr 27 (1999) 185-190
3. Kaufer D. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease. Dement Geriatr Cogn Disord 9 Suppl 2 (1998) 8-14
4. Mahlberg R., Walther S., Eichmann U., Tracik F., and Kunz D. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study. Archives of Gerontology and Geriatrics 45 (2007) 19-26
5. Tariot P.N., Solomon P.R., Morris J.C., Kershaw P., Lilienfeld S., and Ding C. A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology 54 (2000) 2269-2276
6. Cummings J.L. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 48 Suppl 6 (1997) S10-S16
7. Kaufer D.I., Cummings J.L., Christine D., Bray T., Castellon S., Masterman D., et al. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc 46 (1998) 210-215